When is Cystatin C clinically relevant?
Cystatin C is most useful when it is interpreted together with the symptom pattern, the relevant category context, and the broader diagnostic question behind the test.
Cystatin C is a protein produced by all nucleated cells that serves as an internal marker for kidney filtration rate. It is used to assess glomerular filtration rate (GFR) and detect kidney impairment.
Cystatin C should not be read as an isolated number only. This short overview summarizes when the marker matters, which questions it does not answer on its own, and what broader context makes the result more useful.
Cystatin C is most useful when it is interpreted together with the symptom pattern, the relevant category context, and the broader diagnostic question behind the test.
Cystatin C does not replace symptom timing, functional assessment, or the wider clinical picture. A marker may be informative without being the whole answer.
The next useful step is usually to connect Cystatin C to related markers, symptoms, and the broader context of the test rather than reading it as an isolated endpoint.
Cystatin C is a low-molecular-weight protein that is produced at a constant rate by nearly all cells in the body. It is freely filtered by the kidneys’ glomeruli and then almost completely reabsorbed and broken down in the proximal tubules, so only small amounts appear in the urine.
Because its blood level depends primarily on kidney filtration, Cystatin C is a reliable marker for estimating the glomerular filtration rate (GFR). Unlike creatinine, Cystatin C is less influenced by muscle mass, age, or sex, making it a useful alternative or complement to standard kidney function tests.
A Cystatin C level below the reference range (under 0.5 mg/L, lab-dependent) is uncommon and usually not clinically significant. It can occur in early pregnancy or in individuals with very low muscle mass. Low levels generally do not indicate a health problem.
An elevated Cystatin C level (above 1.0 mg/L, lab-dependent) usually reflects reduced kidney filtration capacity. This may be a sign of acute or chronic kidney disease, dehydration, or conditions that impair renal function. Higher levels correlate with a lower GFR, and the test is often used to detect early kidney damage that might be missed by creatinine alone.
This result is not specific for ME/CFS or Long COVID. Read it together with the clinical question, symptoms, related findings and the laboratory reference range rather than in isolation.
Practical details are separated from the general FAQ so they are easier to find.
Cystatin C is most useful when it is interpreted together with the symptom pattern, the relevant category context, and the broader diagnostic question behind the test.
Cystatin C is an alternative to creatinine for estimating GFR. It is less affected by muscle mass, age, sex, and diet, making it more reliable in certain populations like the elderly, malnourished, or those with abnormal muscle mass. In some cases, combining both markers provides a more accurate kidney function assessment.
The next useful step is usually to connect Cystatin C to related markers, symptoms, and the broader context of the test rather than reading it as an isolated endpoint.
You now know which questions can matter when reading this result. With Elara you can keep the value and its surrounding context together over time.
Save the lab value with its date so individual measurements do not get lost.
See previous measurements together instead of relying on a single snapshot.
View Cystatin C alongside symptom, energy, sleep and PEM entries without assuming one caused the other.
Export your history as a PDF — structured for the next check-up.
Normal Cystatin C levels typically range from 0.5 to 1.0 mg/L (lab-dependent). Some laboratories may use slightly different ranges. Your result should be compared to the reference interval provided by the testing lab.
A high Cystatin C level suggests that the kidneys are not filtering blood as well as they should. This can indicate acute kidney injury, chronic kidney disease, or other conditions affecting kidney function. It is often used to calculate an estimated GFR.
Cystatin C does not replace symptom timing, functional assessment, or the wider clinical picture. A marker may be informative without being the whole answer.
This biomarker gains value when it is connected to symptom patterns, daily function, and structured self-observation instead of being read in isolation.
Reduced capacity, multisystem symptoms, and delayed worsening often make more sense when the broader ME/CFS pattern is considered.
Markers linked to sleep, stress, recovery, hormones, or metabolism often become more useful when viewed through pacing and daily load management.
Questionnaires help connect biomarkers to symptom patterns, functional limits, and patient-reported change over time.
Markers from the same system can add useful context when a single lab value is hard to interpret on its own.
No individual medical review is documented.
This English content was created with AI assistance and automatically validated. This is not an individual medical review.
This information does not replace medical advice. Lab values should be assessed in the context of your medical history, the reason for testing and other findings. Elara provides health information for orientation — not diagnoses or treatment decisions.
Bring your lab values, symptoms and energy into one shared context — so you walk into your next appointment more informed and structured.